Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbidopa, Levodopa and Entacapone Tablets.".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbidopa, Levodopa and Entacapone Tablets.".